MedTrace Logo

Effect of an Oral Acerola Juice Powder on Skin Beauty Parameters in Women Exposed to Environmental Stresses

NCT07229131 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2026-02-18

No results posted yet for this study

Summary

The study is being conducted to evaluate the efficacy and the safety of an oral acerola-based product on skin ageing parameters.

Conditions

  • Pollution; Exposure

Interventions

DIETARY_SUPPLEMENT

Acerola Juice Powder 1200 mg/day

4 capsules per day, each capsule containing 300mg of Acerola and 100 mg of maltodextrin

DIETARY_SUPPLEMENT

Acerola Juice Powder 600 mg/day

4 capsules/day, each capsule containing 150 mg of Acerola and 250 mg of Maltodextrin

OTHER

Placebo

4 capsules per day, each capsule containing 400 mg of maltodextrin

Sponsors & Collaborators

  • Eurofins Dermscan Pharmascan

    collaborator INDUSTRY

  • Diana SAS

    lead INDUSTRY

Principal Investigators

  • Sarah ZENG · EUROFINS CONSUMER PRODUCT TESTING (Guangzhou)Co.,Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-03
Primary Completion
2026-02-13
Completion
2026-02-13

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07229131 on ClinicalTrials.gov